UNSPSC 51281632: Amikacin sulfate

This classification denotes an aminoglycoside antibiotic with the molecular formula C22H43N5O13.2H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N6M33094FD, chemically known as d-streptamine, o-3-amino-3-deoxy-alpha-d-glucopyranosyl-(1->6)-o-(6-amino-6-deoxy-alpha-d-glucopyranosyl-(1->4))-n(sup 1)-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (s)- but more generally known as amikacin sulfate, which bears US NIH Compound Identifier 37768. The base compound, Amikacin, most often comes in dihydrate, disulfate, hydrate, and sulfate forms.

UNSPSC 51281632 Amikacin sulfate is a Commodity code for a specific injectable antibiotic pharmaceutical product. State and local governments procure this drug through cooperative purchasing agreements and piggyback contracts to support public health initiatives, emergency preparedness, and community health programs. The work involves sourcing pharmaceutical inventory from qualified distributors and manufacturers to meet public health agency needs.

Illinois Department of Public Health is a representative issuing body under this code's broader pharmaceutical procurement activity. The most recent documented opportunity is a completed piggyback pharmaceutical warehouse contract awarded to Chartwell Rx LLC through the MMCAP Infuse consortium (Solicitation 26482DPHPREPDB53392, posted August 28, 2026), though that award specifically covered Doxycycline Hyclate and Ciprofloxacin Hydrochloride rather than amikacin. A second recent state-local opportunity—Seminole County, Florida's IFB60459723LAS for Naloxone and Safe Drug Deactivation Systems (posted June 30, 2026, due July 26, 2023)—shows activity in the broader pharmaceutical procurement space but does not directly reference amikacin. The recent-opportunities block contains no open solicitations specifically for amikacin sulfate. Activity is concentrated in Illinois and Florida based on the recent records, though cooperative purchasing vehicles like MMCAP Infuse and piggyback arrangements suggest potential reach across multiple states where health departments participate in multi-state purchasing consortia.